Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seoul National University Bundang Hospital
After taking Amozatan (AMS, amlodipine / rozanthin combination) in patients with essential hypertension, the percentage of patients who reached the mean systolic target blood pressure was evaluated
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or rosartan monotherapy
In patients with stage 2 hypertension (SBP 160-179 mmHg), patients requiring a combination therapy to reach the target blood pressure
Patients who were changed to amosartan while using other hypertensive agents
You may not be if
Patients with hypersensitivity to dihydropyridine derivatives of amosartan
Women who are pregnant or who may be pregnant and breastfeeding
Patients with severe hepatic dysfunction
Patients with severe aortic stenosis
Patients at risk of shock
Patients participating in other clinical studies
Clareo Health | Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
